[Federal Register: February 6, 2008 (Volume 73, Number 25)]
[Notices]               
[Page 7004]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06fe08-85]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated March 22, 2007 and published in the Federal 
Register on March 29, 2007, (72 FR 14832), Roche Diagnostics Operation, 
Inc., Attn: Regulatory Compliance, 9115 Hauge Road, Indianapolis, 
Indiana 46250, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of the basic 
classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I
Alphamethadol (9605).......................  I
Tetrahydrocannabinols (7370)...............  I
Cocaine (9041).............................  II
Ecgonine (9180)............................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
the manufacture of diagnostic products for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Roche Diagnostics Operations, Inc. to import the basic 
class of controlled substance is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Roche Diagnostics Operations, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substances 
listed.

    Dated: January 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-2141 Filed 2-5-08; 8:45 am]

BILLING CODE 4410-09-P